Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2001
09/12/2001EP1132376A1 Beta-amyloid protein production/secretion inhibitors
09/12/2001EP1132361A1 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds
09/12/2001EP1131388A1 Electroluminescent materials
09/12/2001EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes
09/12/2001EP1131296A2 Synthesis of intermediates useful in preparing tricyclic compounds
09/12/2001EP1131292A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
09/12/2001EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
09/12/2001EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof
09/12/2001EP0749424B1 Naphthalene derivatives as prostaglandin i2 agonists
09/12/2001CN1312807A Inhibitors of glycogen synthase kinase 3
09/12/2001CN1312800A Therapeutic biaryl derivatives
09/12/2001CN1312678A Biocidal composition and its use
09/12/2001CN1070841C Carboxylic acid derivatives, their preparation and their use
09/12/2001CN1070700C Process for preparation of medicine containing flupirtine and use to combat muscular tension thereof
09/11/2001US6288825 Electrochromic media for producing a preselected color and devices comprising same
09/11/2001US6288267 Thioamide derivatives
09/11/2001US6288266 Halogenated acrylates or thioacrylates for polymers
09/11/2001US6288235 Multistage reaction with amidation, cleavage from resin support and methylation then condensation of methyl ester to give 2,4-dioxopiperidine compounds
09/11/2001US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288092 Triaryl compounds
09/11/2001US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/11/2001US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation
09/11/2001US6288083 Chemokine receptor antagonists and methods of use therefor
09/11/2001US6288071 1-ethylene-2-alkylene-1,4-cyclohexadiene pesticides
09/11/2001US6288055 Analgesic agents
09/11/2001CA2031570C Substituted cyclohexenes as central nervous system agents
09/07/2001WO2001064826A2 Composition and method for bleaching a substrate
09/07/2001WO2001064692A1 Cardioprotective phosphonates and malonates
09/07/2001WO2001064644A1 Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
09/07/2001WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
09/07/2001WO2001064642A2 Benzamides and related inhibitors of factor xa
09/07/2001WO2001055111A8 Biaryl compounds, their preparation and their use in therapy
09/07/2001WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
09/07/2001WO2001018008A3 Decahydronaphthalene derivatives for molecular signal transduction
09/07/2001WO2001010383A3 Caspase inhibitors and uses thereof
09/07/2001WO2001000197A3 Methods of treating fungal infections with inhibitors of nad synthetase enzyme
09/07/2001WO2000075107A3 Bradykinin receptor antagonists
09/07/2001CA2401039A1 Composition and method for bleaching a substrate
09/06/2001US20010020112 Aromatization of cyclohexenone derivatives via (chloro)cyclohexadiene
09/06/2001US20010020033 Selective factor xa inhibitors
09/06/2001US20010020024 Opioid analgesics
09/06/2001US20010020021 Metalloprotease inhibitor
09/06/2001US20010020013 Polymerase inhibitors
09/06/2001US20010019720 Using 6-carbamoyl-2-pyridine carboxylic acid
09/06/2001DE10008522A1 Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen Use of 2-phenylenediamine for the treatment of infections
09/05/2001EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors
09/05/2001EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments
09/05/2001EP1129064A1 Transfection reagents
09/05/2001EP0873304B1 Metalloproteinase inhibitors
09/05/2001EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists
09/05/2001EP0801527A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
09/05/2001EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
09/05/2001CN1311773A Neuropeptide Y5 receptor antagonists
09/05/2001CN1311768A Crosslinkable liquid crystalline compound
09/05/2001CN1311185A Method for preparing 4-amino pyridine and its derivatives
09/04/2001USRE37355 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/04/2001USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses
09/04/2001US6284924 Bis/oxynaphthalene derivatives of carboxylic acids
09/04/2001US6284894 Preparation of allylic aromatic compounds
09/04/2001US6284893 Process for producing nitrile compounds
09/04/2001US6284877 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound
09/04/2001US6284796 Naphthamidine compounds
09/04/2001US6284795 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
09/04/2001US6284780 Prevent tumor necrosis factor retrovirus reproduction
09/04/2001US6284777 Carbohydrazide protease inhibitors
09/04/2001US6284768 Src family SH2 domain inhibitors
09/04/2001CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
08/2001
08/30/2001WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
08/30/2001WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
08/30/2001WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
08/30/2001WO2001062732A1 Water-based composition containing pyrithione having micaceous shape
08/30/2001WO2001062731A1 Pyridine-amidines as modulators of p38 map kinase
08/30/2001WO2001062715A1 Novel cd23 inhibitors
08/30/2001WO2001062713A1 Novel phenylheteroalkylamine derivatives
08/30/2001WO2001062709A2 Use of 2-phenylene diamine derivatives for the treatment of infections
08/30/2001WO2001062708A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
08/30/2001WO2001062705A2 Aminoalcohol derivatives
08/30/2001WO2001062704A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001WO2001062253A1 Compositions and methods for treatment of epilepsy
08/30/2001WO2001062233A2 Adenosine receptor modulators
08/30/2001WO2001016272A3 Ligand and complex for catalytically bleaching a substrate
08/30/2001WO2001016261A3 Composition and method for bleaching a substrate
08/30/2001WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
08/30/2001WO2000071510A3 INHIBITORS OF FACTOR Xa
08/30/2001US20010018526 Reacting alkyl halide with a pyridine compound or imidazole compound; heating in chemical reactor
08/30/2001US20010018525 Modulating blood glucose concentration
08/30/2001US20010018524 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
08/30/2001US20010018523 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
08/30/2001US20010018446 Atherosclerosis, dyslipemia
08/30/2001US20010018441 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents
08/30/2001US20010018438 Nervous system disorders; psychological disorders
08/30/2001US20010018405 For use as plant protecting fungicides, by reacting an orthocarbonate with a compound such as a 2-(1,1-dipropoxymethyleneamino)thiophene-3-carboxylic acid propyl amide and cyclizing the resulting intermediate
08/30/2001CA2401190A1 Pyridine-amidines as modulators of p38 map kinase
08/30/2001CA2401030A1 Use of 2-phenylene diamine derivatives for the treatment of infections
08/30/2001CA2400491A1 Compositions and methods for treatment of epilepsy
08/30/2001CA2397234A1 Novel use of phenylheteroalkylamine derivatives
08/30/2001CA2396971A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
08/29/2001EP1127897A2 Catalyst composition comprising specific iron or cobalt complexes and process for the oligomerization or polymerization of ethylene therewith
08/29/2001EP1127884A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them